76b911d9 386e 488f 9ace 21e784cf0a97 01
Allopurinol Tablet
Product Images NDC 70771-1127
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 70771-1127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
76b911d9 386e 488f 9ace 21e784cf0a97 02
76b911d9 386e 488f 9ace 21e784cf0a97 03
NDC 70771-1126 is a bottle of Allopurinol tablets, USP containing 100 tablets of 100mg allopurinol each. This medication is intended for prescription use only and must be kept out of children's reach. The accompanying package insert should be consulted for indications, dosage, precautions, and other vital information. The Cadila Healthcare Ltd of Badd, India produces these tablets.*
76b911d9 386e 488f 9ace 21e784cf0a97 04
Each tablet contains Allopurinol, USP 300mg. This medication is used to treat gout and certain types of kidney stones. It helps to reduce high uric acid levels in the blood. The recommended dosage and precautions should be followed as stated in the USP. The tablets should be stored at room temperature and kept out of the reach of children. The medication is manufactured by Cadla Healthcare Ltd in India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
